MétaCan
Menu
Back to cohort
Record W3097806446 · doi:10.1183/23120541.00520-2020

COVID-19 in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: a reference centre survey

2020· article· en· W3097806446 on OpenAlex

Why this work is in the frame

A frame that forgets how it found something cannot be audited. These are the routes that admitted this work.

aboutThe title or abstract carries a Canadian signal from the geographic lexicon.
no affNo Canadian affiliation: this work is invisible to an affiliation-only frame.
No Canadian affiliation. An affiliation-only frame, the usual design, would never have seen this work. It is one of the works that make the case for inverting the frame.

Bibliographic record

VenueERJ Open Research · 2020
Typearticle
Languageen
FieldMedicine
TopicPulmonary Hypertension Research and Treatments
Canadian institutionsnot available
FundersUniwersytet WarszawskiRigshospitaletWarszawski Uniwersytet MedycznyErasmus Medisch CentrumEuropean Respiratory Society
KeywordsMedicinePulmonary hypertensionConcomitantCoronavirus disease 2019 (COVID-19)Chronic thromboembolic pulmonary hypertensionLungInternal medicineDiseaseRight heart catheterizationIntensive care medicineInfectious disease (medical specialty)

Abstract

fetched live from OpenAlex

According to the US Centers for Disease Control and Prevention (CDC), patients with underlying health conditions, including all types of lung and cardiovascular diseases, have an increased risk of developing serious disease when infected by SARS-CoV-2 [1]. Based on prior publications on the effects of acute right heart failure superimposed on systemic infection [2–5], Ryan et al. [6] suggested that right heart failure and concomitant COVID-19 infection may result in increased mortality in pulmonary arterial hypertension (PAH) patients. Surprisingly, the number of hospitalised PAH-COVID-19 patients remained rather low in Italy and the USA so far [7]. In late March 2020, experts from over 32 US PH expert centres answered a query endorsed by the US Pulmonary Hypertension Association. COVID-19 infection was reported in 13 PAH patients, among whom three required intubation and one died. This is consequently raising the question whether and why PAH patients appear to be at lower risk of developing severe COVID-19 [7]. This international survey highlights that a limited number of PAH and CTEPH patients suffered from severe #COVID19 infection <https://bit.ly/3jGuBQq> This survey is a common initiative of European Respiratory Society (ERS) Assembly 13 on Pulmonary Vascular Diseases, ERS Clinical Research Collaboration PHAROS and European Reference Network for Rare Lung Diseases (ERN-lung), and is endorsed by patient association PHA Europe. We thank Valerija Arsovski from the ERS office in Lausanne (Switzerland) for logistic support and the survey participants: Yochai Adir (Carmel Medical Center, Haifa, Israel), Joan Barbera (Hospital Clínic, Barcelona, Spain), Roberto J. Bernardo (Stanford University, CA, USA), Laurent Bertoletti (University Hospital, Saint-Etienne, France), Aleksandar Bokan (Institute for pulmonary diseases of Vojvodina, Sremska Kamenica, Serbia), Karin Boomars (Erasmus Medical Center, Rotterdam, The Netherlands), Jørn Carlsen (Rigshospitalet, University of Copenhagen, Copenhagen, Denmark), Michele D'Alto (Monaldi Hospital, University “L. Vanvitelli”, Naples, Italy), Anna Doboszynska (Pulmonary Department, Warmia-Mazury University, Olsztyn, Poland), Aleksandra Furdyna (Department of Internal Medicine, Medical University of Warsaw, Warshaw, Poland), Sean Gaine (Mater Dublin, Dublin, Ireland), Henning Gall (Lung Center, University of Giessen, Giessen, Germany), Pitsiou Georgai (Aristotle University Thessaloniki, G.H.G.Papanikolaou, Thessaloniki, Greece), Pavel Jansa (General University Hospital, Prague, Czech Republic), Wojciech Jacheć (Department of Cardiology Zabrze, Medical University of Silesia, Katowice, Poland), Carlos Jardim (Heart Institute, University of Sao Paulo, Sao Paulo, Brazil), Elena Jurevičienė (University Hospital Santaros Klinikos, Vilnius, Lithuania), Dominic Keating (Alfred Hospital, Melbourne, Australia), Derya Kocakaya (Marmara University Hospital, Istambul, Turkey), Lisa Kohlbacher (Medical University, Vienna, Austria), Yaroslav Kondratsky (Regional Clinical Hospital, Lviv, Ukraine), Beata Kusmierczyk (National Institute of Cardiology, Warsaw, Poland), Irene Lang (Medical University, Vienna, Austria), Tobias Lange (University Medical Center, Regensburg, Germany), Skaidrius Miliauskas (Hospital of Lithuanian university of health sciences, Kaunas, Lithuania), Karen Olsson (Medical School, Hannover, Germany), Gul Öngen (Cerrahpaşa Medical Faculty, Istambul, Turkey), Caneva Jorge Osvaldo (Fundacion Favaloro, Buenos Aires, Argentina), Małgorzata Peregud-Pogorzelska (Department of Cardiology, Pomeranian Medical University, Szczecin, Poland), Georgai Pitsiou (Aristotle University Thessaloniki, G.H.G.Papanikolaou, Thessaloniki, Greece), Rui Plácido (Academic Medical Centre, Lisbon, Portugal), Tomas Pulido (National Heart Institute, Mexico City, Mexico), Farid Rashidi (University of Medical Sciences, Tabriz, Iran), Abilio Reis (Centro Hospitalar Universitário, Porto, Portugal), Olivier Sitbon (Kremlin-Bicêtre Hospital, Paris, France), Jesús Ribas Sola (Hospital Universitari de Bellvitge, Barcelona, Spain), John Ryan (University of Utah, Salt Lake City, UT, USA), Sandeep Sahay (Houston Methodist Hospital, Houston, TX, USA), Silvia Ulrich (University Hospitals, Zurich, Switzerland), Jolanda van Haren-Willems (Radboud University Medical Centre, Nijmegen, The Netherla,ds), Alexander Volkov (Institute of Rheumatology, Moscow, Russian Federation), Anton Vonk Noordegraaf (University Medical Center Amsterdam, The Netherlands), Jason Weatherald (University of Calgary, Calgary, Canada), Helen Whitford (The Alfred Hospital, Melbourne, Australia) and Katarzyna Widejko (Copper Medical Centre, Legnica, Poland), for having kindly answered the survey.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.002
metaresearch head score (Gemma)0.003
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesMeta-epidemiology (narrow), Insufficient payload (model declined to judge)
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.535
Threshold uncertainty score1.000

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0020.003
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0010.000
Bibliometrics0.0000.002
Science and technology studies0.0010.000
Scholarly communication0.0000.000
Open science0.0010.002
Research integrity0.0000.001
Insufficient payload (model declined to judge)0.0020.001

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.291
GPT teacher head0.418
Teacher spread0.127 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it